|
||
Article |
| ABSTRACT |
|---|
|
|
|---|
Key Words: potassium channels dihydropyridines
| introduction |
|---|
|
|
|---|
Although DHPs have profound effects on L-type Ca2+ channels, it was shown that these compounds also affected voltage-dependent Na+ channels (Yatani et al., 1988
) and voltage-dependent K+ channels (Jacobs and DeCoursey, 1990
; Gotoh et al., 1991
). Using the whole cell voltage-clamp method, Jacobs and DeCoursey (1990)
tested a series of clinically relevant agents, including nifedipine, on the K+ currents in alveolar epithelial cells and found that nifedipine produced apparent inactivation. They suggested that nifedipine, at least in part, works by acting as an open channel blocker. Gotoh et al. (1991)
studied the effect of nicardipine on the K+ channel current in rabbit heart cells. They found that nicardipine accelerated the time course of the outward K+ current decline with the 50% inhibitory concentration of 630 nM. This is fourfold higher than that for the Ca2+ current in the same cells (160 nM).
The structural elements involved in the DHP binding to the Ca2+ channels are not thoroughly understood. Biochemical experiments (Nakayama et al., 1991
; Regulla et al., 1991
) using antibody mapping indicated that DHPs may bind to the amino acid residues in the S6 segment of the
1 subunit of the Ca2+ channel. Some investigators (Glossmann et al., 1984
; Triggle et al., 1989
) have suggested that Ca2+ channels may have two DHP binding sites, a high-affinity site (nM range) and a low-affinity site (µM range). A mutagenesis study using chimeric channels based on two distinct Ca2+ channels with different DHP affinities shows that the S5, Pore, and S6 segments may be important in determining the DHP sensitivity (Grabner et al., 1996
). A molecular simulation study showing how a DHP may bind to the Ca2+ channel pore with Ca2+ ions bound suggests that DHPs occlude the channel pore (Zhorov and Ananthanarayanan, 1996
).
We investigated the effects of DHPs on the Shaker K+ channels expressed in Xenopus oocytes. Native cells may express more than one class of K+ channels and the interpretations of the results of the drug action are usually not straightforward. Heterologous expression of a single class of channel can largely overcome this problem. Since the biophysical gating properties of the Shaker channel have been studied extensively (Bezanilla et al., 1994
; Hoshi et al., 1994
; Stefani et al., 1994
; Zagotta et al., 1994
a,b), any alterations in the channel gating can be more easily detected and studied. Furthermore, molecular manipulations of the Shaker channel affecting some of the gating transitions, such as inactivation rates, have been described (Hoshi et al., 1990
, 1991
; Zagotta et al., 1990
; Lopez-Barneo et al., 1993
), and they can be used to probe the interactions of the channel with DHPs. The results obtained in this study indicate that DHPs interact with the open state of the Shaker channel inducing apparent inactivation although the drugs do not act as simple open-channel blockers. The results also show that the overall DHP efficacy can be modulated by a single amino acid mutation in the S6 segment.
| materials and methods |
|---|
|
|
|---|
6-46 contains a 41-residue deletion in the amino terminus and lacks N-type inactivation (Hoshi et al., 1990
6-46 T449V contains a single amino acid substitution at position 449 (using the ShB numbering) from T to V. The ShB
6-46 T449V channel has disrupted N-type inactivation and drastically slowed or disrupted C-type inactivation (Lopez-Barneo et al., 1993
6-46 T449K has a point mutation at position 449 from T to K to accelerate C-type inactivation to a more experimentally manageable range (Lopez-Barneo et al., 1993
6-46 T449V: A463I has an additional point mutation at position 463 that has been shown to be involved in C-type inactivation (Hoshi et al., 1991
Electrophysiological Recording
In most experiments, the single channel and macroscopic patch currents were recorded using excised configurations of the patch-clamp technique (Hamill et al., 1981
; Methfessel et al., 1986
) with an AxoPatch 200A amplifier (Axon instruments, Foster City, CA). The macroscopic patch currents were low-pass filtered through an eight-pole Bessel filter unit with 2 kHz corner frequency (Frequency Devices, Haverhill, MA) and digitized at 10 kHz using an ITC16 computer interface (Instrutech, Great Neck, NY). The whole oocyte currents were recorded using a Warner OC-725B (Warner, Hamden, CT) two-electrode voltage clamp amplifier. The electrodes filled with 3 M KCl had a typical resistance of less than 0.5 M
. The data were collected and analyzed using Pulse/PulseFit (HEKA, Lambrecht, Germany), IGOR PRO (Wavemetrics, Lake Oswego, OR), TAC (SKALAR, Seattle, WA), and DataDesk (DataDescriptions, Ithaca, NY) programs running on Apple Macintosh computers. Unless otherwise indicated, the linear capacitative and leak currents have been subtracted from the macroscopic currents presented using a modified P/n protocol. The single channel data were idealized using the half amplitude threshold method. For the analysis of the single channel dwell times, additional exponential components were included only if the probability of requiring one additional component was >0.95 using the likelihood ratio test (Hoshi et al., 1994
). Numerical simulations of the ionic currents predicted by the kinetic schemes were performed using the Q-matrix approach (Colquhoun and Hawkes, 1995
) implemented in IGOR. The parameters of the schemes were optimized by minimizing the chi-squared value using the downhill simplex algorithm (Press et al., 1994
) implemented in IGOR. When appropriate, the data values are presented as mean ± standard deviation. The error bars are not shown when smaller than the symbol size. All experiments were performed at room temperature (20–24°C).
Solutions
The intracellular solution typically contained (in mM): 140 KCl, 11 EGTA, 10 HEPES, pH 7.2 (titrated with n-methyl-D-glucamine [NMG]). The extracellular solution typically contained (in mM): 140 NaCl, 2 MgCl2, 2 KCl, 10 HEPES (NMG), pH 7.2. The high K+ extracellular solution contained (in mM): 140 KCl, 2 MgCl2, 10 HEPES (NMG), pH 7.2. Other solutions used are indicated in the legends.
Nifedipine (Sigma Chemical Co., St. Louis, MO), Bay K 8644 (RBI, Natick, MA), and nimodipine (Sigma) were dissolved in 100% ethanol (10 mM). Nicardipine (Sigma) was dissolved in 100% methanol (5 mM). The stock solutions were kept in the dark at <4°C. The drug solutions were prepared fresh from these stock solutions and vortexed immediately before each use.
| results |
|---|
|
|
|---|
6-46 T449V channel contains a deletion in the amino terminus to disrupt N-type inactivation (Hoshi et al., 1990
6-46 T449V channel since the gating transitions are simplified with the N- and C-type inactivation mechanisms disrupted. Because internal Mg2+ ions are known to induce voltage-dependent block of currents through Shaker -like potassium channels (Ludewig et al., 1993
Nifedipine Induces Apparent Inactivation
Application of nifedipine to the intracellular side induced a time-dependent decline in the ionic currents through the ShB
6-46 T449V channels. Fig. 1 A shows the effects of intracellular nifedipine (50 µM) on the ShB
6-46 T449V K+ currents elicited in response to depolarizing voltage pulses. The amplitudes of the control ShB
6-46 T449V currents did not decline appreciably with maintained depolarization. Most of the reduction in the control current amplitude observed with maintained depolarization is attributable to accumulation of K+ ions in the extracellular space immediately adjacent to the channels as judged by the changes in the reversal potential of the tail currents with time (data not shown). In the presence of nifedipine, the currents underwent marked apparent inactivation at the positive voltages where the activation process is fast, suggesting that nifedipine exerts its action after the channel opens. The current-voltage (I-V) curves indicate that the reduction of the current amplitude by nifedipine is apparently voltage dependent (Fig. 1 B).
|
|
6-46 T449V currents (Fig. 2 B). The vehicles (ethanol, methanol) did not induce the inactivation at the concentrations used.
Other Dihydropyridines Are Also Effective
In addition to nifedipine, other DHPs are also effective in inducing apparent inactivation in the Shaker channels. Fig. 3 compares the intracellular applications of nimodipine, nicardipine, and BAY K 8644 (+,–) on the ShB
6-46 T449V currents elicited in response to the voltage pulses to +50 mV. As with nifedipine, these DHPs induced apparent inactivation in a reversible manner when applied to the intracellular side. Extracellular applications of these drugs were also much less effective (data not shown).
|
30 µM (Fig. 4 C). For nimodipine, the half-maximal reduction was observed at a slightly lower concentration (Fig. 4 E). With greater concentrations, the apparent inactivation time course became faster and the steady-state current became progressively smaller. These results are again consistent with the drugs exerting the action after the channel opens. The fractions of the currents blocked at the end of the sweep are shown in Fig. 4 C (nifedipine) and E (nimodipine). The time constants of the current decline are shown in Fig. 4 D (nifedipine) and F (nimodipine). These plots illustrate a slight difference in the efficacies of nifedipine and nimodipine. The Hill plot transformations of the block data (Fig. 4 B) indicate that the concentration dependence of both nifedipine and nimodipine block has the Hill coefficient of 1.5, consistent with more than one DHP molecule binding to the channel.
|
6-46 T449V:A463I, which contains a single amino acid substitution at position 463 (Hoshi et al., 1991
6-46 T449V background was used. The A463I mutation increases the single channel amplitude by 50%, and it increases the mean open time by 20–30-fold. Thus, this channel is well suited to assay the DHP effects. Representative openings of a single ShB
6-46 T449V:A463I channel recorded at 0 mV are shown in Fig. 5 A. Application of nifedipine decreased the mean open time in a concentration-dependent manner (Fig. 5, B and C). The reduction of mean open time is consistent with nifedipine interacting with the open state of the channel. The amplitude of the main conductance state of the channel was not markedly affected by nifedipine application. Although we observed the substates more frequently in the presence of nifedipine, we did not systematically investigate this issue.
|
6-46 channel, Cf (Hoshi et al., 1994
6-46 (Hoshi et al., 1994
6-46 T449V:A463I channel also showed an additional component with a time constant value of 50–200 ms with a small fractional amplitude (3% in the data shown). Nifedipine (100 µM) did not introduce an additional closed duration component in a statistically significant way but noticeably increased the relative amplitude of the third component (from 3% to 11% in Fig. 6). It is possible that nifedipine did induce an extra component, but the new time constant was too similar to one of the existing time constants to be detected. Similar results were obtained from two other single-channel patches.
|
|
6-46 T449K channel. This channel mutant has a 41–amino acid deletion in the amino terminus to disrupt N-type inactivation (Hoshi et al., 1990
6-46 T449K channels in control and in presence of 100 µM nifedipine are shown in Fig. 7 C and rate constants obtained from two exponential current fits are shown in Fig. 7 D. In the presence of nifedipine (100 µM), the current decline was faster than that in the absence of the drug. The results suggest that nifedipine and C-type inactivation do not compete.
If nifedipine induces the apparent inactivation in the ShB
6-46 T449V channel by enhancing the residual C-type inactivation mechanism, the nifedipine-induced inactivation should display properties similar to those of C-type inactivation. For example, the nifedipine-induced inactivation should slow down in the presence of high external K+ as C-type inactivation is slowed by high external K+ (Lopez-Barneo et al., 1993
). We tested this hypothesis by comparing the efficacies of the nifedipine block in the presence of different external K+ concentrations. As compared in Fig. 7 E, the time course of the nifedipine block with 140 mM external K+ was not slower than that observed with 2 or 50 mM external K+. Thus, the nifedipine-induced inactivation and C-type inactivation differ in their sensitivities to external K+, suggesting that they are mediated by distinct mechanisms. This does not, however, rule out the possibility that nifedipine and C-type inactivation interact as suggested by the results obtained with the ShB
6-46 T449K channel (Fig. 7, C and D).
Voltage Dependence of the DHP Block
Because nifedipine is not a charged molecule, it was not expected that its action would be voltage dependent even if it might position itself in the membrane electric field. We examined the possible voltage dependence of the DHP action as shown in Fig. 8. The channels were opened first in response to a voltage pulse to +50 mV to allow the nifedipine molecules to block the channels. Then, the membrane voltage was changed to a variety of voltages where the steady-state probability of the channel being open is still saturated (Zagotta et al., 1994
a). If the DHP action is voltage independent, the only instantaneous and time-independent changes in the current, reflecting the changes in the driving force, should be observed, as recorded under control conditions (Fig. 8 A). The presence of the time-dependent relaxation of the current would suggest that the drug action is voltage dependent. The results in Fig. 8, B–D do show such time-dependent relaxation. The time courses of the current relaxations were fitted with single exponentials and the ratios of the extrapolated instantaneous current amplitudes to the steady state currents are shown in Fig. 8 E. DHPs became less effective in blocking the current with greater depolarization. As a data description parameter for the voltage dependence, we chose the number of apparent equivalent charges (n). The value n was obtained by fitting the relative block data (Fig. 8 E) with the following function
![]() |
|
6-46 T449V current are shown in Fig. 8 E as the solid lines. The apparent charge number is plotted against the DHP concentration in Fig. 8 F. The voltage dependence increased with the drug concentration. The data also show a difference in the voltage dependence of nifedipine and nimodipine blocks of the ShB
6-46 T449V currents as well as a difference in the voltage dependence of nifedipine block of the ShB
6-46 T449V current (Fig. 8 F, circles) and the ShB
6-46 T449V:A463I current (squares).
Nifedipine Interaction with Ion Flow through Channel
The results presented so far suggest that nifedipine interacts with the open state of the channel to impede the ion flow. One possible mechanism is that nifedipine physically occludes the ion conducting pore, acting as an open channel blocker. Several molecules have been shown to act as open channel blockers for voltage-dependent K+ channels, including TEA, and the Shaker inactivation peptide (Demo and Yellen, 1991
). If nifedipine acts as an open channel blocker, K+ flux through the channel should regulate the block efficacy.
The effects of the direction of the net K+ flow on the nifedipine efficacy are shown in Fig. 9. With 140 mM K+ outside, the effects of nifedipine on the net inward and outward currents were measured at +30 mV with 0 mM and 140 mM K+ inside, respectively. The reduction in the steady state current caused by nifedipine was not markedly altered by the changes in the net current flow, suggesting that DHP efficacy is independent of the direction of the net current flow.
|
6-46 T449V, where both the N- and C-type inactivation mechanisms are disrupted, mutating the residue 463 from A to I (ShB
6-46 T449V:A463I) causes the mean open time and the single channel amplitude to increase (see Fig. 5). Consistent with the slow channel closing rate, the macroscopic G(V) curve of this channel is shifted to a more negative direction by
40 mV compared with that of ShB
6-46 or ShB
6-46 T449V (data not shown). We found that the effects of nifedipine on ShB
6-46 T449V:A463I are distinct from those on ShB
6-46 T449V. The effects of nifedipine on the ShB
6-46 T449V:A463I channel differ in three major areas: steady-state fraction of the current blocked, recovery from the nifedipine block, and voltage dependence of the block. Nifedipine (100 µM) was less effective in blocking the ShB
6-46 T449V:A463I channel than the ShB
6-46 T449V channel. Fig. 10 B compares the concentration dependence of nifedipine block of the ShB
6-46 T449V (circles) and ShB
6-46 T449V: A463I (squares) currents, also showing that nifedipine is less effective on the ShB
6-46 T449V:A463I channel. A difference in the voltage dependence of nifedipine block of these two channel types is shown in Fig. 8 F using the same symbols.
|
6-46 T449V and ShB
6-46 T449V: A463I channels. The tail current was slowed by nifedipine in the ShB
6-46 T449V channels (Fig. 10 C). In contrast, nifedipine accelerated the time course of deactivation in the ShB
6-46 T449V:A463I channel at all the voltages examined (–100 to –140 mV). | discussion |
|---|
|
|
|---|
Our consideration of the possible biophysical and molecular mechanisms underlying the DHP action on the Shaker channels is based on the description of their gating process in Zagotta et al. (1994
b). This scheme can be presented in a simplified form as the following:
where CR represents the numerous closed states that the channel visits before opening, and Cf represents the closed state(s) that the channel enters after opening. At positive voltages, the value of the reverse rate constant β* is small, and the fast transitions between Cf and O can be assumed to be at equilibrium. This scheme SIs well suited for the description of the gating behavior of ShB
6-46 T449V, which shows neither C- or N-type inactivation in Xenopus oocytes (Hoshi et al., 1990
; Lopez-Barneo et al., 1993
). Although in this scheme, activation of the channel is represented with a single transition for simplicity, in numerical simulations we used the complete model as described in Zagotta et al. (1994
b). Values of all the rate constants were taken from Zagotta et al. (1994
b). All the blocking schemes considered below are based on SCHEME SI as they are reduced to this scheme SIn the absence of drug.
|
where DHP·O represents the drug-bound non-conducting open state. According to this scheme, the mean open time should decrease in a concentration-dependent manner in the presence of nifedipine. The mean open time was indeed decreased by nifedipine as shown in Fig. 5. Furthermore, according to SCHEME SII, the reciprocal of the mean open time should be linearly related to the DHP concentration by the following relationship:
![]() |
|
is voltage dependent could be considered: An obvious drawback of this scheme SIs that it does not predict the concentration-dependent mean open time. This can be resolved by combining SCHEMES II and III into a single scheme:
This model has four more free parameters than SCHEME SI, and it can account for the effect of DHP on the mean open time and the voltage dependence of the block. This model, however, does not describe the concentration dependence curve well (Fig. 4) and it predicts a Hill coefficient of 1 as opposed to the observed higher value (Fig. 4 B), which requires binding of more than one DHP molecules to the channel. Thus, we introduce the following model:
(SCHEME v)
Time constants of the current decline, voltage dependence of the block and the concentration dependence predicted by SCHEMES II and V were simulated and shown superimposed on the experimental data (Figs. 4, 8, and 10). For these computations, all parameters in the absence of drug were fixed at the values given in Zagotta et al. (1994
b). Only the block/unblock rates included in each scheme were adjusted by minimizing the chi square value to simultaneously fit the steady-state fractional block (Fig. 4, C and E) and the time constant of the current decline in the presence of nifedipine and nimodipine (Fig. 4, D and F). Table I shows the parameter values used to simulate the data. The predictions of SCHEME SV with two DHP binding steps are markedly better than those of SCHEME SII with one binding step (Fig. 4). With the rate constant values obtained from fitting the concentration dependence, SCHEME SV also reproduces the voltage dependence of the block even though the parameters were not specifically optimized to fit the voltage dependence (Fig. 8 F).
|
|
The model in SCHEME SV can be used to explain the altered drug sensitivity of the ShB
6-46 T449V:A463I channel. In the ShB
6-46 T449V:A463I channel, the occupancy probability in the Cf state is lower than that in the ShB
6-46 T449V channel as this channel has a greater mean open time. Thus, according to SCHEME SV, where the second DHP molecule binds only to the Cf state, the ShB
6-46T449V:A463I channel should be less sensitive to DHP than the ShB
6-46 T449V channel, as opposed to SCHEME ii, in which the increased occupancy of the open state should favor increased blocking. This prediction is consistent with the data obtained (see Fig. 10), where ShB
6-46T449V:A463I is less sensitive to DHP. The shift in G(V) curve of the ShB
6-46T449V:A463I channel could be well represented by decreasing the rate constants of the transitions away from the open state (
and O-Cf as given in the model of Zagotta et al., 1994
b) by a factor of 10, thus stabilizing the open state by
1.3 kcal/mol. The concentration dependence given by SCHEME SV with the block rates obtained from the ShB
6-46T449V data with the open state stabilized by 1.3 kcal/mol is shown in Fig. 10 B. With those values, SCHEME SV produces less block, which is consistent with the observed effect. We consider the results of the simulations based on SCHEME SVto be in qualitative agreement with the observed effects. SCHEME SV reasonably describes the concentration and voltage dependence of DHP block as well as the effect of A463I mutation. There are ways to further increase the agreement between the model prediction and the experimental data. For example, it is possible to improve the general fit by assuming that allosteric interactions increase the rate of DHP binding to the Cf (DHPB) state compared with that to the O state. Since the available experimental data did not specifically discriminate the various possible allosteric models, we did not consider them further.
The observation that DHP is not likely to compete with C-type inactivation (Fig. 6) suggests that C-type inactivation itself can occur from the fast closed state, which is stabilized by the bound DHP molecule. Because C-type inactivation is slowed by K+ ions (Lopez-Barneo et al., 1993
; Baukrowitz and Yellen, 1996
), it is reasonable to speculate that C-type inactivation occurs from the fast closed state or other nonconducting states (Baukrowitz and Yellen, 1996
). Baukrowitz and Yellen (1996)
showed that internal TEA derivatives enhance C-type inactivation by emptying K+ ions from the pore. Similarly, DHP may have two effects on the Shaker channel. First, binding of the DHP itself to the channel decreases the K+ flux. The reduced K+ ion occupancy in the channel pore in turn increases the residual C-type inactivation rate.
Although a mutation in the S6 segment affected the DHP efficacy (Fig. 10), it is likely that other amino acid residues are also involved in regulating the DHP efficacy. For example, considering that DHP preferentially works from the intracellular side, the residues in the internal mouth of the channel may also be involved. Those amino acid residues in the S5, P, and S6 segments shown to be important for the 4-aminopyridine block (Kirsch et al., 1993
) are also good candidates for involvement in the DHP sensitivity. However, since the DHP efficacy does not appear to be markedly influenced by the net K+ flux (Fig. 9), the DHP molecules probably do not lie directly in the K+ flux pathway.
A large number of dihydropyridines have been synthesized and these drugs appear to have different potencies in blocking the Shaker potassium channel (Fig. 3; unpublished observation). At the same concentration, nimodipine appears be more effective than nifedipine (Fig. 4). However, minor quantitative changes in the rate constants of the model in SCHEME SV can account for the observed differential potency, suggesting that the underlying biophysical mechanisms are the same. Furthermore, by comparing the effects of different dihydropyridines with different side groups, it should be possible to gain information on which structural components of the drug are critical in determining the different rate constants of the model.
Several µM of nifedipine was required to observe noticeable effects on the ShB channel currents at +50 mV whereas the drug's effects on L-type Ca2+ channels may be observed in the nM range. Despite the higher concentration required to affect the Shaker potassium channels, the effects are specific in that the UV-treated nifedipine is ineffective. Because the DHP action on Shaker channels is enhanced by hyperpolarization, it is possible that the efficacy may be greater under physiological conditions where the transmembrane potential may not reach +50 mV. It is also possible that other homologues of Shaker channels show much higher DHP sensitivities than the channels examined in this study. Given the structural similarities found in different voltage-dependent ion channels, it will be interesting to rigorously compare the biophysical and molecular mechanisms of the DHP action on voltage-dependent Ca2+ and K+ channels.
|
|
1 Abbreviations used in this paper: DHP, dihydropyridine; NMG, n-methyl- D-glucamine; TEA, tetraethylammonium.
| ACKNOWLEDGMENTS |
|---|
Submitted: 9 May 1996
Accepted: 21 October 1996
| references |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Druzin, D. Haage, E. Malinina, and S. Johansson Dual and opposing roles of presynaptic Ca2+ influx for spontaneous GABA release from rat medial preoptic nerve terminals J. Physiol., July 1, 2002; 542(1): 131 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mitra and M. M. Slaughter Calcium-induced Transitions between the Spontaneous Miniature Outward and the Transient Outward Currents in Retinal Amacrine Cells J. Gen. Physiol., April 1, 2002; 119(4): 373 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lin, Z. Wang, and D. Fedida Influence of permeating ions on Kv1.5 channel block by nifedipine Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1160 - H1172. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, D. V. Miller, and W. G. Paterson Opposing roles of K+ and Cl- channels in maintenance of opossum lower esophageal sphincter tone Am J Physiol Gastrointest Liver Physiol, December 1, 2000; 279(6): G1226 - G1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bénardeau, J. Weissenburger, L. Hondeghem, and E. A. Ertel Effects of the T-Type Ca2+ Channel Blocker Mibefradil on Repolarization of Guinea Pig, Rabbit, Dog, Monkey, and Human Cardiac Tissue J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 561 - 575. [Abstract] [Full Text] |
||||
![]() |
R. G. Tsushima, A. D. Wickenden, R. A. Bouchard, G. Y. Oudit, P. P. Liu, and P. H. Backx Modulation of Iron Uptake in Heart by L-Type Ca2+ Channel Modifiers : Possible Implications in Iron Overload Circ. Res., June 11, 1999; 84(11): 1302 - 1309. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanabe, B. H. Gahwiler, and U. Gerber L-Type Ca2+ Channels Mediate the Slow Ca2+-Dependent Afterhyperpolarization Current in Rat CA3 Pyramidal Cells In Vitro J Neurophysiol, November 1, 1998; 80(5): 2268 - 2273. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Ogielska and R. W. Aldrich A Mutation in S6 of Shaker Potassium Channels Decreases the K+ Affinity of an Ion Binding Site Revealing Ion-Ion Interactions in the Pore J. Gen. Physiol., August 1, 1998; 112(2): 243 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Marten and T. Hoshi Voltage-dependent gating characteristics of the K+ channel KAT1 depend on the N and C termini PNAS, April 1, 1997; 94(7): 3448 - 3453. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mitra and M. M. Slaughter Calcium-induced Transitions between the Spontaneous Miniature Outward and the Transient Outward Currents in Retinal Amacrine Cells J. Gen. Physiol., April 1, 2002; 119(4): 373 - 388. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|